Moors & Cabot’s Amgen AMGN Stock Holding History

Moors & Cabot’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,100	Closed	-$1K	–	671
2019 Q2	$1K	Hold	1,100	–	–	﹤0.01%	553
2019 Q1	$1K	Buy	+1,100	New	+$210K	﹤0.01%	527
2016 Q3	–	Sell	-1,100	Closed	-$2K	–	550
2016 Q2	$2K	Buy	+1,100	New	+$171K	﹤0.01%	517
2016 Q1	–	Sell	-1,100	Closed	-$2K	–	524
2015 Q4	$2K	Buy	+1,100	New	+$173K	﹤0.01%	514

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Moors & Cabot's AMGN Position: Q1 2026 in Review

Moors & Cabot reduced its Amgen (AMGN) stake by 2.6% in Q1 2026, selling an estimated $141K and leaving 15,025 shares worth $5.29M. The position accounts for 0.23% of the portfolio, ranked #95.

Moors & Cabot first reported a position in AMGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $7.4M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Moors & Cabot held 15,025 shares of Amgen worth $5.29M as of Q1 2026.
Moors & Cabot sold 395 Amgen shares in Q1 2026, an estimated $141K.
Amgen made up 0.23% of Moors & Cabot's portfolio in Q1 2026, its #95 holding.
Moors & Cabot first reported a position in Amgen in Q1 2014 and has held it in 49 quarters since.
Moors & Cabot's Amgen position peaked at $7.4M in Q4 2019.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.